THENA Capital Secures £27M for UK Medtech and Women’s Health

THENA Capital, a pioneering venture fund helmed by an all-female leadership team, has secured £27M in the initial close of its £50M fund. Specialising in early-stage medtech, the London-based firm aims to revolutionise both the UK’s healthcare innovation landscape and the venture capital industry by focusing on emerging digital health solutions and medical devices, particularly in women’s health.

As the UK’s first specialised medtech venture fund led by women, THENA Capital, founded by Tatum Getty, Pamela Walker Geddes, and Esther Reynal dae St Michel Richardot, brings a wealth of diverse expertise to the table. The founders have backgrounds in scaling health and wellness companies across different nationalities—French, American, and Canadian—bringing a unique perspective to the venture capital sector. Their fund addresses critical funding voids in medtech, which is vital to the UK’s economy and its position as a global leader in life sciences. The fund boasts support from prestigious investors, including the British Business Bank’s Enterprise Capital Funds programme and various industry leaders.

THENA Capital’s launch comes at a crucial time for women’s health investment. By placing a spotlight on femtech, the fund strives to rectify both the funding disparity in women’s health startups and the gender gap within healthcare itself. As they forge a path for others to follow, THENA Capital not only promises to advance patient care but also aims to redefine industry norms, championing diversity and innovation in health tech VC.

For the latest updates and in-depth insights into the world of Medical Devices, including breakthrough treatments, industry trends, and regulatory news, contact Holly Haynes today!